Effect of Short-term Preoperative Dutasteride on Bleeding after Transurethral Resection of the Prostate
Journal of Nepalgunj Medical College · 31.12.2025 · 23 (2) · 35-38
DOI: 10.3126/jngmc.v23i2.90549 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nepalgunj Medical College, online erschienen am 31.12.2025. Verfasst von Anup Karki und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Transurethral resection of the prostate is the gold-standard surgical treatment for moderate to severe lower urinary tract symptoms due to benign prostatic hyperplasia unresponsive to medical therapy. Bleeding is the most frequent postoperative complication, leading to clot retention, prolonged hospitalization, and increased morbidity. Dutasteride, a 5-alpha-reductase inhibitor, reduces dihydrotestosterone levels, suppresses Vascular Endothelial Growth Factor expression, and decreases prostate vascularity, thereby potentially reducing perioperative bleeding.
Aims
To evaluate the effect of 2-weeks preoperative dutasteride therapy on bleeding during TURP.
Methods
This prospective interventional study was conducted at Nepalgunj Medical College from September to November 2025. Fifty patients were divided into two groups: Group A received dutasteride 0.5 mg/day for two weeks before Transurethral resection of the prostate, and Group B underwent surgery without dutasteride. All patients underwent standard preoperative evaluations and surgery was performed using a uniform technique by blinded surgeons. Postoperative outcomes were assessed based on hemoglobin and hematocrit changes, clot retention, and hospital stay.
Results
Baseline characteristics were similar between groups. Group A showed significantly less postoperative drop in Hemoglobin (0.66 ± 0.55 g/dl vs 1.12 ± 0.72 g/dl; P=0.016) and Hematocrit(4.53 ± 3.09% vs 8.75 ± 2.02%; P=0.02). No patients in Group A developed clot retention, whereas two cases in Group B needed clot evacuation. Hospital stay was significantly shorter in Group A (2.28 ± 0.54 vs 3.08 ± 0.91 days; P=0.000).
Conclusion
Short-term preoperative dutasteride therapy significantly reduces bleeding during Transurethral resection of the prostate and shortens hospital stay
Zitieren
APA
Karki, A., Shrestha, N. M., Khaniya, S., & Subedi, R. (2025). Effect of Short-term Preoperative Dutasteride on Bleeding after Transurethral Resection of the Prostate. Journal of Nepalgunj Medical College, 23(2), 35-38. https://doi.org/10.3126/jngmc.v23i2.90549
Vancouver
Karki A, Shrestha NM, Khaniya S, Subedi R. Effect of Short-term Preoperative Dutasteride on Bleeding after Transurethral Resection of the Prostate. Journal of Nepalgunj Medical College. 2025;23(2):35-38. doi:10.3126/jngmc.v23i2.90549
BibTeX
@article{Karki2025,
author = {Karki, Anup and Shrestha, Naresh Man and Khaniya, Sushil and Subedi, Ratan},
title = {Effect of Short-term Preoperative Dutasteride on Bleeding after Transurethral Resection of the Prostate},
journal = {Journal of Nepalgunj Medical College},
year = {2025},
volume = {23},
number = {2},
pages = {35--38},
doi = {10.3126/jngmc.v23i2.90549}
}
EUVIMED